About Us

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. We are headquartered in Cambridge, UK with eleven additional locations across Asia, the UK, and the USA.

Products

We manufacture our own products in our specialist facilities worldwide, as well as sourcing from over 400 partners. This way we are able to offer scientists the newest and best research tools available globally regardless of source.  See our products.

Customers

Our customers are research scientists who need high performance products with detailed technical specifications. Our information-rich products, together with expert customer support and fast delivery makes us the researcher’s choice.

People

Our team is our biggest asset and we are proud to have over 140 in-house PhDs. Nurturing employee excellence is key to our success and we continue to invest in the learning and development of staff. For more information click here

Our business model

Our business model is designed to deliver sustainable long-term value for all of our stakeholders.

plc-graphic-green

 

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +